Breaking News Instant updates and real-time market news.

HSDT

Helius Medical

$9.40

-0.4 (-4.08%)

, PDVW

pdvWireless

$33.93

0.03 (0.09%)

04:55
10/02/18
10/02
04:55
10/02/18
04:55

PubCoCEO to hold a conference

MicroCap Conference 2018 will be held in New York on October 1-2.

HSDT

Helius Medical

$9.40

-0.4 (-4.08%)

PDVW

pdvWireless

$33.93

0.03 (0.09%)

ADIL

Adial Pharmaceuticals

$2.76

-0.24 (-8.00%)

NAKD

Naked Brand Group

$2.41

-0.29 (-10.74%)

OGEN

Oragenics

$1.60

0.46 (40.35%)

CURR

CURE Pharmaceutical

$0.00

(0.00%)

JTPY

JetPay

$2.10

0.1 (5.00%)

ISDR

Issuer Direct

$15.31

-0.64 (-4.01%)

INPX

Inpixon

$0.21

0.0031 (1.54%)

XXII

22nd Century

$2.78

-0.03 (-1.07%)

PRLX

Parlex Corp.

$0.00

(0.00%)

KMDA

Kamada

$6.22

0.065 (1.06%)

LMAT

LeMaitre

$37.24

-1.48 (-3.82%)

DXR

Daxor

$5.44

0.18 (3.42%)

SNOA

Sonoma Pharmaceuticals

$1.54

(0.00%)

  • 02

    Oct

  • 04

    Oct

  • 04

    Oct

  • 05

    Oct

HSDT Helius Medical
$9.40

-0.4 (-4.08%)

06/19/18
BTIG
06/19/18
DOWNGRADE
BTIG
Neutral
Helius Medical downgraded to Neutral from Buy at BTIG
06/19/18
BTIG
06/19/18
DOWNGRADE
BTIG
Neutral
Helius Medical downgraded to Neutral at BTIG on delay in PNS clearance
As reported, BTIG analyst Sean Lavin downgraded Helius Medical to Neutral from Buy citing yesterday's announced delay in filing for the FDA clearance of its Portable Neuromodulation Stimulator investigational medical device in Q3 rather than Q2. The analyst notes that the delay raises the risk of the company running out of cash before clearance and may force it to raise more capital, putting the spotlight on the management's credibility. Lavin adds that given the rise in the stock price to his prior target of $14, a Neutral rating is "more appropriate".
05/17/18
05/17/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Costco (COST) initiated with a Buy at Loop Capital. 2. Align Technology (ALGN) initiated with an Outperform at Evercore ISI. 3. Baxter (BAX) assumed with an Overweight at Piper Jaffray. 4. Comtech (CMTL) initiated with a Neutral at Citi. 5. Helius Medical (HSDT) initiated with a Buy at BTIG. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/17/18
BTIG
05/17/18
INITIATION
Target $14
BTIG
Buy
Helius Medical initiated with a Buy at BTIG
BTIG analyst Sean Lavin initiated Helius Medical with a Buy rating and a price target of $14, saying the company's offerings have the "potential to help people with traumatic brain injuries to regain normal function, balance, and the ability to walk." Lavin adds that Helius Medical's Portable Neuromodulation Stimulator is shown to produce "significant improvement in balance and function" in patients, who have "no other good options", expecting the company to target workers' comp, the military, and normal medical insurers. He also expects the investment story to result in positive public sentiment, driving adoption and reimbursement. The analyst does note some risks for the company, including its recently missed primary efficacy endpoint. which could prompt the FDA to ask for more data. as well as the company's impending capital needs.
PDVW pdvWireless
$33.93

0.03 (0.09%)

ADIL Adial Pharmaceuticals
$2.76

-0.24 (-8.00%)

10/01/18
DAWS
10/01/18
INITIATION
Target $6
DAWS
Adial Pharmaceuticals at Dawson James
Dawson James initiated Adial Pharmaceuticals with a Buy and $6 price target.
NAKD Naked Brand Group
$2.41

-0.29 (-10.74%)

OGEN Oragenics
$1.60

0.46 (40.35%)

CURR CURE Pharmaceutical
$0.00

(0.00%)

JTPY JetPay
$2.10

0.1 (5.00%)

04/25/18
BRRR
04/25/18
INITIATION
Target $3
BRRR
Outperform
JetPay initiated with an Outperform at Barrington
Barrington analyst Gary Prestopino started JetPay with an Outperform rating and $3 price target.
ISDR Issuer Direct
$15.31

-0.64 (-4.01%)

09/07/18
NORL
09/07/18
INITIATION
Target $21
NORL
Outperform
Issuer Direct initiated with an Outperform at Northland
Northland analyst Mike Grondahl initiated Issuer Direct with an Outperform and $21 price target saying it has developed into a leader in disclosure management, communications and compliance services for both public and private companies.
INPX Inpixon
$0.21

0.0031 (1.54%)

XXII 22nd Century
$2.78

-0.03 (-1.07%)

PRLX Parlex Corp.
$0.00

(0.00%)

KMDA Kamada
$6.22

0.065 (1.06%)

02/02/18
CHDN
02/02/18
INITIATION
Target $7
CHDN
Buy
Kamada initiated with a Buy at Chardan
Chardan analyst Keay Nakae initiated Kamada with a Buy and $7 price target.
LMAT LeMaitre
$37.24

-1.48 (-3.82%)

06/08/18
06/08/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pfizer (PFE) and Eli Lilly (LLY) were initiated with an Overweight at Cantor Fitzgerald. 2. LivaNova (LIVN) initiated with a Buy at Stifel. 3. Occidental Petroleum (OXY) and Chevron (CVX) were initiated with a Buy at Mizuho while ConocoPhillips (COP) and Exxon Mobil (XOM) were initiated with a Neutral. 4. LeMaitre (LMAT) resumed with a Buy at Roth Capital. 5. Savara (SVRA) initiated with an Outperform, sees 300% upside, says Evercore ISI. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/26/18
04/26/18
UPGRADE
Target $40

Buy
LeMaitre upgraded to Buy amid 'excessive' selloff at Benchmark
As previously reported, Benchmark analyst Raymond Myers upgraded LeMaitre Vascular to Buy from Hold as he believes the 20% post-earnings selloff in the shares is "excessive." He attributes the Q1 earnings shortfall mainly to sales execution issues and thinks management has already taken the necessary steps to fix the problems, he tells investors. Myers, who sees plans to expand the sales force leading to accelerating revenue growth in 2019, set a $40 price target on LeMaitre shares.
06/25/18
LSCM
06/25/18
INITIATION
Target $45
LSCM
Buy
LeMaitre initiated with a Buy at Lake Street
Lake Street analyst Brooks O'Neil initiated LeMaitre Vascular with a Buy rating and $45 price target, contending that its recent biologics-focused acquisitions give it rapidly growing niche products that its sales organization can cross-sell to its installed base of vascular surgeons to expand its "already successful business."
06/08/18
ROTH
06/08/18
INITIATION
Target $38
ROTH
Buy
LeMaitre resumed with a Buy at Roth Capital
Roth Capital analyst Scott Henry resumed coverage of LeMaitre Vascular with a Buy rating and $38 price target, as he expects resumed sales-force expansion to drive organic growth in the near-term and thinks the company's Reddick divestiture could help fund an acquisition, which could be a catalyst.
DXR Daxor
$5.44

0.18 (3.42%)

SNOA Sonoma Pharmaceuticals
$1.54

(0.00%)

03/05/18
MAXM
03/05/18
DOWNGRADE
MAXM
Hold
Sonoma Pharmaceuticals downgraded to Hold from Buy at Maxim
03/05/18
03/05/18
DOWNGRADE

Hold
Sonoma Pharmaceuticals downgraded to Hold after capital raise at Maxim
As previously reported, Maxim analyst Jason Kolbert downgraded Sonoma Pharmaceuticals to Hold from Buy after the company raised capital by selling shares in secondary offering that priced at $3.50 per share. After adjusting his model for the new share count he believes that there is only modest upside in the stock at current levels, said Kolbert, who sees catalysts as lacking over the next 12 months.
07/20/18
07/20/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. OneMain Holdings (OMF) reinstated with an Equal Weight at Barclays. 2. Viking Therapeutics (VKTX) initiated with a Buy at SunTrust. 3. Semtech (SMTC) initiated with a Buy at Stifel. 4. Axon (AAXN) initiated with a Buy at Needham. 5. Sonoma Pharmaceuticals (SNOA) assumed with a Speculative Buy at Benchmark. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/20/18
BNCH
07/20/18
INITIATION
Target $3
BNCH
Speculative Buy
Sonoma Pharmaceuticals assumed with a Speculative Buy at Benchmark
Benchmark analyst Bruce Jackson assumed coverage of Sonoma Pharmaceuticals with a Speculative Buy rating and $3 price target, stating that he sees execution risk as the company pivots to a more profitable revenue model but that a higher multiple is possible if Sonoma can improve its cash flow and margins.

TODAY'S FREE FLY STORIES

01:55
02/20/19
02/20
01:55
02/20/19
01:55
General news
Asian Market Wrap: »

Asian Market Wrap:…

LUV

Southwest

$57.66

0.02 (0.03%)

21:49
02/19/19
02/19
21:49
02/19/19
21:49
Downgrade
Southwest rating change at Goldman Sachs »

Southwest downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

RARE

Ultragenyx

$56.80

0.14 (0.25%)

21:17
02/19/19
02/19
21:17
02/19/19
21:17
Recommendations
Ultragenyx analyst commentary at Piper Jaffray »

Piper Jaffray positive on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

21:05
02/19/19
02/19
21:05
02/19/19
21:05
General news
Japan's exports fell 8.4% in January »

Japan's exports fell…

PANW

Palo Alto Networks

$230.19

3.46 (1.53%)

20:49
02/19/19
02/19
20:49
02/19/19
20:49
Downgrade
Palo Alto Networks rating change at Gabelli »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 25

    Feb

  • 26

    Feb

  • 04

    Mar

  • 05

    Mar

AROC

Archrock

$10.06

0.365 (3.76%)

20:33
02/19/19
02/19
20:33
02/19/19
20:33
Earnings
Archrock sees FY19 net income $73M-$103M vs. $29.2M in FY18 »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

CTL

CenturyLink

$14.10

0.37 (2.69%)

20:32
02/19/19
02/19
20:32
02/19/19
20:32
Downgrade
CenturyLink rating change at RBC Capital »

CenturyLink downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 11

    Mar

TTD

Trade Desk

$161.76

3.69 (2.33%)

20:31
02/19/19
02/19
20:31
02/19/19
20:31
Downgrade
Trade Desk rating change at Stifel »

Trade Desk downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

CVS

CVS Health

$69.92

0.39 (0.56%)

, SO

Southern Company

$48.91

0.35 (0.72%)

20:25
02/19/19
02/19
20:25
02/19/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

CVS

CVS Health

$69.92

0.39 (0.56%)

SO

Southern Company

$48.91

0.35 (0.72%)

ADI

Analog Devices

$104.21

-1.49 (-1.41%)

HSIC

Henry Schein

$63.11

0.73 (1.17%)

OC

Owens Corning

$55.38

0.73 (1.34%)

WIX

Wix.com

$125.70

4.31 (3.55%)

WWW

Wolverine World Wide

$39.50

-0.04 (-0.10%)

CNDT

Conduent

$14.52

0.93 (6.84%)

OMI

Owens & Minor

$7.94

0.25 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 12

    Mar

  • 18

    Mar

  • 19

    Mar

  • 09

    Apr

  • 28

    May

AROC

Archrock

$10.06

0.365 (3.76%)

20:21
02/19/19
02/19
20:21
02/19/19
20:21
Earnings
Archrock reports Q4 EPS 10c, consensus 8c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AI

Arlington Asset Investment

$8.70

-0.14 (-1.58%)

20:09
02/19/19
02/19
20:09
02/19/19
20:09
Syndicate
Arlington Asset Investment 6M share Spot Secondary priced at $8.33 »

Arlington Asset announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

GLD

SPDR Gold Shares

$126.70

1.89 (1.51%)

19:46
02/19/19
02/19
19:46
02/19/19
19:46
Hot Stocks
SPDR Gold Shares holdings fall to 792.45MT from 793.03MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$305.56

-2.2 (-0.71%)

19:17
02/19/19
02/19
19:17
02/19/19
19:17
Hot Stocks
Tesla CEO says company will make about 500,000 cars in 2019 »

Tesla CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 18

    Mar

  • 19

    Mar

IDCC

InterDigital

$73.13

-0.26 (-0.35%)

19:06
02/19/19
02/19
19:06
02/19/19
19:06
Hot Stocks
InterDigital says LG Electronics extends license to use Hillcrest's Freespace »

InterDigital, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

TWTR

Twitter

$31.64

0.41 (1.31%)

19:03
02/19/19
02/19
19:03
02/19/19
19:03
Hot Stocks
Tesla CEO says 4,000 cars loading in San Francisco for Europe »

Tesla CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

OSPN

OneSpan

$16.78

0.645 (4.00%)

, HSTM

HealthStream

$26.95

0.09 (0.34%)

19:01
02/19/19
02/19
19:01
02/19/19
19:01
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

OSPN

OneSpan

$16.78

0.645 (4.00%)

HSTM

HealthStream

$26.95

0.09 (0.34%)

LNTH

Lantheus

$19.18

0.67 (3.62%)

CDNS

Cadence Design

$52.65

0.09 (0.17%)

CRMT

America's Car-Mart

$81.74

-0.43 (-0.52%)

DVN

Devon Energy

$28.31

-0.11 (-0.39%)

LMAT

LeMaitre

$25.09

-0.01 (-0.04%)

FIVN

Five9

$54.31

0.1 (0.18%)

NVTA

Invitae

$16.49

0.43 (2.68%)

LZB

La-Z-Boy

$32.23

0.845 (2.69%)

DK

Delek US

$34.87

0.025 (0.07%)

VRSK

Verisk Analytics

$124.45

-0.93 (-0.74%)

WIRE

Encore Wire

$56.32

1.32 (2.40%)

HLF

Herbalife Nutrition

$57.46

0.8 (1.41%)

TVTY

Tivity Health

$21.67

0.28 (1.31%)

IIN

IntriCon

$29.43

2 (7.29%)

LC

LendingClub

$3.62

0.05 (1.40%)

CXO

Concho Resources

$120.95

-2.03 (-1.65%)

FANG

Diamondback Energy

$104.75

-0.78 (-0.74%)

TXRH

Texas Roadhouse

$65.58

0.03 (0.05%)

SSTI

ShotSpotter

$48.18

2.2 (4.78%)

OMI

Owens & Minor

$7.94

0.25 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 21

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 04

    Mar

  • 11

    Mar

  • 12

    Mar

  • 12

    Mar

  • 13

    Mar

  • 13

    Mar

  • 14

    Mar

  • 18

    Mar

  • 28

    Mar

  • 22

    May

  • 28

    May

HBM

Hudbay Minerals

$6.35

0.365 (6.10%)

18:58
02/19/19
02/19
18:58
02/19/19
18:58
Hot Stocks
Hudbay Minerals announces increased reserves at Lalor mine »

Hudbay Minerals announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

HBM

Hudbay Minerals

$6.35

0.365 (6.10%)

18:56
02/19/19
02/19
18:56
02/19/19
18:56
Hot Stocks
Hudbay Minerals reports Q4 copper output 37.2K tonnes, down 14% from last year »

Reports Q4 gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

CLXT

Calyxt

$13.56

0.15 (1.12%)

18:55
02/19/19
02/19
18:55
02/19/19
18:55
Hot Stocks
Calyxt, Agtegra Cooperative announce strategic collaboration »

Calyxt and Agtegra…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBM

Hudbay Minerals

$6.35

0.365 (6.10%)

18:54
02/19/19
02/19
18:54
02/19/19
18:54
Earnings
Hudbay Minerals reports Q4 EPS (1c), consensus 18c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

NOC

Northrop Grumman

$287.36

0.44 (0.15%)

18:39
02/19/19
02/19
18:39
02/19/19
18:39
Hot Stocks
Northrop Grumman recommends shareholders to reject offer by TRC Capital »

Northrop Grumman has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$277.89

0.49 (0.18%)

18:31
02/19/19
02/19
18:31
02/19/19
18:31
Periodicals
POTUS says U.S. corn sales to China part of trade talks, Bloomberg says »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$277.89

0.49 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$9.69

0.11 (1.15%)

18:29
02/19/19
02/19
18:29
02/19/19
18:29
Hot Stocks
Aphria announces early termination of Liberty Health Sciences divestment »

Aphria announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$18.01

0.02 (0.11%)

, AGN

Allergan

$137.94

-1.13 (-0.81%)

18:26
02/19/19
02/19
18:26
02/19/19
18:26
Hot Stocks
Teva finalizes settlement with FTC to resolve all outstanding litigation »

Teva Pharmaceutical…

TEVA

Teva

$18.01

0.02 (0.11%)

AGN

Allergan

$137.94

-1.13 (-0.81%)

ABBV

AbbVie

$80.50

-0.35 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 22

    Feb

  • 25

    Feb

  • 18

    May

  • 28

    May

18:25
02/19/19
02/19
18:25
02/19/19
18:25
Conference/Events
CLSA technology analyst to hold an analyst/industry conference call »

Technology Sales…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.